IGC Pharma (IGC) Leases (2020 - 2025)
IGC Pharma (IGC) has disclosed Leases for 6 consecutive years, with $13000.0 as the latest value for Q3 2025.
- Quarterly Leases fell 91.93% to $13000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13000.0 through Sep 2025, down 91.93% year-over-year, with the annual reading at $98000.0 for FY2025, 50.51% down from the prior year.
- Leases for Q3 2025 was $13000.0 at IGC Pharma, down from $16000.0 in the prior quarter.
- The five-year high for Leases was $538000.0 in Q2 2021, with the low at $13000.0 in Q3 2025.
- Average Leases over 5 years is $292105.3, with a median of $295000.0 recorded in 2023.
- The sharpest move saw Leases dropped 2.71% in 2021, then crashed 91.93% in 2025.
- Over 5 years, Leases stood at $482000.0 in 2021, then fell by 25.93% to $357000.0 in 2022, then crashed by 36.41% to $227000.0 in 2023, then tumbled by 43.17% to $129000.0 in 2024, then tumbled by 89.92% to $13000.0 in 2025.
- According to Business Quant data, Leases over the past three periods came in at $13000.0, $16000.0, and $98000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.